Search research articles
Contact Us
Filters
Showing results (381-390 of 459) with videos related to
Page
of 46
Sort By:
ACS Photonics
|
May 5, 2017
High-Power Growth-Robust InGaAs/InAlAs Terahertz Quantum Cascade Lasers
Christoph Deutsch, Martin Alexander Kainz, Michael Krall, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 20, 2017
TSPO PET for glioma imaging using the novel ligand <sup>18</sup>F-GE-180: first results in patients with glioblastoma
Nathalie L Albert, M Unterrainer, D F Fleischmann, et al.
Frontiers in Oncology
|
April 16, 2021
PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging
Adrien Holzgreve, Annamaria Biczok, Viktoria C Ruf, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 8, 2019
Biodistribution and first clinical results of <sup>18</sup>F-SiFAlin-TATE PET: a novel <sup>18</sup>F-labeled somatostatin analog for imaging of neuroendocrine tumors
Harun Ilhan, S Lindner, A Todica, et al.
Neuro-Oncology
|
May 12, 2019
Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients
Norbert Galldiks, Marcus Unterrainer, Natalie Judov, et al.
Neuroimage
|
October 9, 2017
Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [<sup>18</sup>F]GE180 PET quantification
Maximilian Deussing, Tanja Blume, Lena Vomacka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 3, 2025
Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET-An International Multicenter Retrospective Study
Lena M Unterrainer, Thomas A Hope, Wolfgang P Fendler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 17, 2023
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
Simon K B Spohn, Nina-Sophie Schmidt-Hegemann, Juri Ruf, et al.
Plos One
|
May 23, 2018
Association of ocular, cardiovascular, morphometric and lifestyle parameters with retinal nerve fibre layer thickness
Julia Lamparter, Irene Schmidtmann, Alexander K Schuster, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 10, 2021
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy
Paul Rogowski, Christian Trapp, Rieke von Bestenbostel, et al.
Page
of 46
Search research articles
Search
Showing results (381-390 of 459) with videos related to
Sort By:
Page
of 46
ACS Photonics
|
May 5, 2017
High-Power Growth-Robust InGaAs/InAlAs Terahertz Quantum Cascade Lasers
Christoph Deutsch, Martin Alexander Kainz, Michael Krall, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 20, 2017
TSPO PET for glioma imaging using the novel ligand <sup>18</sup>F-GE-180: first results in patients with glioblastoma
Nathalie L Albert, M Unterrainer, D F Fleischmann, et al.
Frontiers in Oncology
|
April 16, 2021
PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging
Adrien Holzgreve, Annamaria Biczok, Viktoria C Ruf, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 8, 2019
Biodistribution and first clinical results of <sup>18</sup>F-SiFAlin-TATE PET: a novel <sup>18</sup>F-labeled somatostatin analog for imaging of neuroendocrine tumors
Harun Ilhan, S Lindner, A Todica, et al.
Neuro-Oncology
|
May 12, 2019
Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients
Norbert Galldiks, Marcus Unterrainer, Natalie Judov, et al.
Neuroimage
|
October 9, 2017
Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [<sup>18</sup>F]GE180 PET quantification
Maximilian Deussing, Tanja Blume, Lena Vomacka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 3, 2025
Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET-An International Multicenter Retrospective Study
Lena M Unterrainer, Thomas A Hope, Wolfgang P Fendler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 17, 2023
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
Simon K B Spohn, Nina-Sophie Schmidt-Hegemann, Juri Ruf, et al.
Plos One
|
May 23, 2018
Association of ocular, cardiovascular, morphometric and lifestyle parameters with retinal nerve fibre layer thickness
Julia Lamparter, Irene Schmidtmann, Alexander K Schuster, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 10, 2021
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy
Paul Rogowski, Christian Trapp, Rieke von Bestenbostel, et al.
Page
of 46